Filters
Other countries
Results: 1 to 12 of 12
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
CCDC22 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
X-Linked Intellectual Disability Panel PreventionGenetics United States | 191 | 141 |
|
Ritscher-Schinzel syndrome 2 (sequence analysis of CCDC22 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Intellectual Disability X-linked Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 136 | 90 |
|
Intellectual Disability & Autism Spectrum Disorders Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 210 | 139 |
|
Ritscher-Schinzel syndrome: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Ritscher-Schinzel Syndrome Type 2 , Sequencing CCDC22 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 318 | 252 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.